SEC Info  
    Home      Search      My Interests      Help      Sign In      Please Sign In

Genzyme Corp – ‘10-K’ for 12/31/06 – EX-21

On:  Thursday, 3/1/07, at 3:26pm ET   ·   For:  12/31/06   ·   Accession #:  1104659-7-15489   ·   File #:  0-14680

Previous ‘10-K’:  ‘10-K’ on 3/10/06 for 12/31/05   ·   Next:  ‘10-K’ on 2/29/08 for 12/31/07   ·   Latest:  ‘10-K/A’ on 3/24/11 for 12/31/10   ·   2 References:   

Find Words in Filings emoji
 
  in    Show  and   Hints

  As Of                Filer                Filing    For·On·As Docs:Size              Issuer               Agent

 3/01/07  Genzyme Corp                      10-K       12/31/06   19:5.7M                                   Merrill Corp-MD/FA

Annual Report   —   Form 10-K
Filing Table of Contents

Document/Exhibit                   Description                      Pages   Size 

 1: 10-K        Annual Report                                       HTML    330K 
 2: EX-10.1.5   Material Contract                                   HTML    252K 
 3: EX-10.11.1  Material Contract                                   HTML    138K 
 4: EX-10.11.2  Material Contract                                   HTML     32K 
 5: EX-10.11.3  Material Contract                                   HTML     50K 
 6: EX-10.12    Material Contract                                   HTML     33K 
 7: EX-10.14    Material Contract                                   HTML     35K 
 8: EX-10.14.1  Material Contract                                   HTML     35K 
 9: EX-10.14.2  Material Contract                                   HTML     34K 
10: EX-10.15.1  Material Contract                                   HTML     30K 
11: EX-10.15.2  Material Contract                                   HTML     32K 
12: EX-13       Annual or Quarterly Report to Security Holders      HTML   2.22M 
13: EX-21       Subsidiaries of the Registrant                      HTML     30K 
14: EX-23       Consent of Experts or Counsel                       HTML     15K 
15: EX-31.1     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
16: EX-31.2     Certification per Sarbanes-Oxley Act (Section 302)  HTML     15K 
17: EX-32.1     Certification per Sarbanes-Oxley Act (Section 906)  HTML     10K 
18: EX-32.2     Certification per Sarbanes-Oxley Act (Section 906)  HTML     10K 
19: EX-99       Miscellaneous Exhibit                               HTML    221K 


EX-21   —   Subsidiaries of the Registrant


This exhibit is an HTML Document rendered as filed.  [ Alternative Formats ]



EXHIBIT 21

SUBSIDIARIES OF THE REGISTRANT

Name

 

 

 

Direct Parent(s)

 

Ownership

 

Jurisdiction of
Incorporation

BioMarin/Genzyme LLC

 

Genzyme Corporation

 

50%

 

 

Delaware

Genzyme Europe B.V.

 

Imtix SangStat (Switzerland) GmbH

 

100%

 

 

The Netherlands

Genzyme Flanders BVBA

 

Genzyme International Holdings Limited

 

99.9%

 

 

Belgium

 

 

SangStat Luxembourg S.à.r.l.

 

0.1%

 

 

 

Genzyme GmbH

 

Genzyme Europe B.V.

 

100%

 

 

Germany

Genzyme International Holdings Limited

 

SangStat Luxembourg S.à.r.l.

 

100%

 

 

Ireland

Genzyme Ireland Limited

 

Genzyme International Holdings Limited

 

100%

 

 

Republic of Ireland

Genzyme Limited

 

Genzyme Corporation

 

100%

 

 

United Kingdom

Genzyme Securities Corporation

 

Genzyme Corporation

 

100%

 

 

Massachusetts

Genzyme Pharmaceuticals AG

 

SangStat Luxembourg S.à.r.l.

 

100%

 

 

Switzerland

Genzyme Polyclonals S.A.S.

 

SangStat Medical, LLC SangStat Atlantique S.A.S.

 

1%

99%

 

 

France

Genzyme Therapeutic
Products Limited Partnership

 

Genzyme Therapeutic

 

1%

 

 

Massachusetts

 

 

Products Corporation

 

 

 

 

 

 

 

Genzyme Therapeutic
Products LLC

 

99%

 

 

 

Genzyme Therapeutic
Products Corporation

 

Genzyme Corporation

 

100%

 

 

Massachusetts

Genzyme Therapeutic
Products LLC

 

Genzyme Corporation

 

100%

 

 

Delaware

Imtix SangStat (Switzerland) GmbH

 

SangStat Luxembourg S.à.r.l.

 

100%

 

 

Switzerland

SangStat Atlantique S.A.S.

 

SangStat Medical, LLC

 

100%

 

 

France

SangStat Luxembourg S.à.r.l.

 

Genzyme Luxembourg S.à.r.l.

 

100%

 

 

Luxembourg

 




2 Subsequent Filings that Reference this Filing

  As Of               Filer                 Filing    For·On·As Docs:Size             Issuer                      Filing Agent

 7/26/07  SEC                               UPLOAD10/16/17    1:16K  Genzyme Corp.
 4/24/07  SEC                               UPLOAD10/16/17    1:61K  Genzyme Corp.
Top
Filing Submission 0001104659-07-015489   –   Alternative Formats (Word / Rich Text, HTML, Plain Text, et al.)

Copyright © 2024 Fran Finnegan & Company LLC – All Rights Reserved.
AboutPrivacyRedactionsHelp — Sat., Apr. 20, 10:12:54.2am ET